www.moovcare.com Open in urlscan Pro
62.128.51.10  Public Scan

Submitted URL: http://moovcare.com/
Effective URL: https://www.moovcare.com/
Submission: On March 06 via api from US — Scanned from DE

Form analysis 1 forms found in the DOM

Name: exit-contact-formPOST https://www.moovcare.com/thanks/?exitPopup=1

<form action="https://www.moovcare.com/thanks/?exitPopup=1" method="post" id="exit-contact-form" name="exit-contact-form">
  <div class="main-contact-form full-div">
    <div class="contact-form-field-container">
      <!--email -->
      <input type="text" value="Email" placeholder="Email" id="exitContactEmail" name="jf_txt_3" alt="Email" title="Email" class="form-field blurme">
    </div>
    <div class="full-div">
      <div class="contact-form-submit ">
        <input style="background-color: #ff5355;" type="button" id="exit-contact-submit" class="genral-button hand c-white transition-bg-color" placeholder="SEND" alt="Submit" title="Submit" value="Submit">
        <div class="contact-submit-arr">
          <img style="max-width:25px;margin: auto;" src="images/white-arr-right.svg" alt="">
        </div>
      </div>
    </div>
  </div>
</form>

Text Content

SIGN UP FOR OUR NEWSLETTER




PLEASE CHOOSE

I Confirm I am aPatient / Carer
I Confirm I am aHealthcare Professional
en |  fr |  ger
Moovcare Log In

AS PATIENT

AS PHYSICIAN

HOME
WHO BENEFITS
TEAM
CLINICAL DEVELOPMENT
PUBLICATIONS & NEWS
TESTIMONIALS
CONTACT


IT'S NEVER TOO EARLY TO DETECT RELAPSE


MOOVCARE® ALERTS YOU TO THE FIRST SIGNS OF TROUBLE SO YOU CAN INTERVENE SOONER


hp_lungs


WHAT IS MOOVCARE®?

Moovcare® is a digital therapeutic that uses a simple weekly questionnaire to
detect relapse or complication during follow-up of lung cancer patients
A Class I medical device, Moovcare® has been proven in clinical trials to
improve overall survival by 7.6 months
For more information download our brochure
Improvement in overall survival +7.6 months



HOW EARLY DETECTION IMPROVES SURVIVAL

Moovcare® dramatically improves survival by monitoring patient symptoms on a
weekly basis and alerting medical teams to the first signs of an anomaly -
allowing for early intervention when the likelihood of successful treatment is
highest.


DETECT EARLIER

CT scans can detect anomalies too late for doctors to treat effectively.
Moovcare monitors and analyzes patient reported symptoms weekly for the first
signs of trouble.


INTERVENE SOONER

The moment an anomaly is detected, an alert is sent to the care team, enabling
them to make an informed decision on whether and how to investigate the matter
further.


OFFER OPTIMAL TREATMENT

By intervening as soon as possible, before the patient’s health deteriorates,
the physician can offer the optimum treatment - thereby increasing the chances
of survival and improving quality of life.

MOOVCARE® HAS PROVED TO BE AN ACCURATE SUPPORT TOOL WITH 100% SENSITIVITY AND
89% SPECIFICITY


MEET MOOVCARE®


THE RIGHT TREATMENT AT THE RIGHT TIME


STANDARD LUNG CANCER FOLLOW-UP.

Problem discovered weeks or months after event


MOOVCARE® LUNG CANCER FOLLOW-UP.

Caregiver alerted the moment a problem is detected


HOW MOOVCARE® WORKS


1

PHYSICIAN PRESCRIBES MOOVCARE® TO PATIENT


2

PATIENT REPORTS SYMPTOMS WEEKLY VIA WEB SURVEY




3

ALGORITHM ANALYZES THE SYMPTOMS




4

IF AN ANOMALY IS DETECTED, ALERT SENT TO MEDICAL TEAM FOR FURTHER INVESTIGATION


The patient can also use Moovcare® to report symptoms they experience between
scheduled visits



A NEW REALITY IN LUNG CANCER FOLLOW-UP

The Moovcare® advantage
Improvement on standard follow-up
Frequency of follow-up
Weekly updates on the patient’s condition
Provides continuous clinical vision between scheduled visits and CTs
General approach
Proactive and dynamic
Adds agility to care in response to changing conditions
Timing
Earliest possible detection offers improved overall survival
Identify problems weeks and months earlier than before
Patient involvement
Patient directly involved in monitoring their own health
Patient empowered, reassured through the active role they play
Communication
Reassured by constant communication with caregiver
Healthier state-of-mind, better qualityof life

Home
Who Benefits
Team
Clinical Development
Publications & News
Testimonials
Contact
Terms
Privacy

ABOUT SIVAN

Find out more about sivan:

    website: www.sivan-innovation.com



MOOVCARE® LUNG:

class I medical device Web application for personalized telemonitoring of
lung cancer patient

SIVAN INNOVATION

(Corporate headquarters)
Hatidhar 15, Raanana, Israel 



SIVAN FRANCE

(European representative)
6 rue Paul Baudry
75008 Paris, France



Current IFU for healthcare professionals
Previous versions of the Instructions for use
© All rights reserved to Sivan Innovation LTD  |  Design & development by:
Webnoise
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of
Service apply.